Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q2 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Symbol
BOLT on Nasdaq
Shares outstanding
38,512,859
Price per share
$0.34
Price from insider filings
$0.34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TANG CAPITAL MANAGEMENT LLC 9.9% $1,525,109 3,812,773 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025

Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$7,330,380 $0.34 0
2025 Q1 18,325,858 $7,330,376 -$193,087 $0.40 28
2024 Q4 18,670,032 $10,001,366 -$530,628 $0.54 36
2024 Q3 18,782,186 $12,170,936 -$2,809,767 $0.65 31
2024 Q2 22,625,730 $16,969,353 -$2,129,242 $0.75 34
2024 Q1 24,001,384 $33,602,029 -$48,851 $1.40 37
2023 Q4 24,125,809 $27,021,270 +$88,269 $1.12 38
2023 Q3 24,542,560 $25,524,580 -$666,580 $1.04 33
2023 Q2 25,033,021 $32,040,661 +$2,557,161 $1.28 38
2023 Q1 23,321,104 $32,404,117 +$3,831,682 $1.39 40
2022 Q4 20,513,167 $26,667,319 -$9,352,183 $1.30 42
2022 Q3 26,715,924 $39,541,135 +$268,501 $1.48 47
2022 Q2 25,977,252 $52,956,628 -$3,740,723 $2.04 52
2022 Q1 28,900,418 $79,202,000 -$19,424,203 $2.74 59
2021 Q4 33,601,118 $164,645,000 -$37,204,660 $4.90 58
2021 Q3 35,321,130 $446,761,381 +$28,297,892 $12.65 69
2021 Q2 33,292,492 $513,799,000 -$29,685,123 $15.46 61
2021 Q1 31,494,590 $1,036,467,376 +$1,036,467,333 $32.91 70